Objective assessment of tumour response to therapy based on tumour growth kinetics.

• Current standards for assessment of tumour response to therapy (a) categorise therapeutic efficacy values, inappropriate for patient-specific and deterministic studies, (b) neglect the natural growth characteristics of tumours, (c) are based on tumour shrinkage, inappropriate for cytostatic therapies, and (d) do not accommodate integration of functional/biological means of therapeutic efficacy assessed with, for example, positron emission tomography or magnetic resonance imaging, with data from anatomical changes in tumour.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Radiologi och bildbehandling (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Radiology, Nuclear Medicine and Medical Imaging (hsv//eng)

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Nyckelord

Cell Growth Processes

Endpoint Determination

methods

Female

Humans

Kinetics

Magnetic Resonance Imaging

Male

Models

Theoretical

Neoplasms

diagnosis

pathology

therapy

Patient Care Planning

Positron-Emission Tomography

Prognosis

Treatment Outcome

Tumor Burden

Publikations- och innehållstyp

ref (ämneskategori)

art (ämneskategori)